What is the ROCE (Return on Capital Employed) of Humanigen this year?
The ROCE of Humanigen is 1.46 undefined this year.
Humanigen ROCE 2025
Humanigen ROCE
1.46
Ticker
HGENQ
ISIN
US4448632038
WKN
A2QEQW
In 2025, Humanigen's return on capital employed (ROCE) was 1.46, a 0% increase from the 0 ROCE in the previous year.
Humanigen Aktienanalyse
What does Humanigen do?
Humanigen Inc is a pharmaceutical company specializing in the discovery, development, and marketing of drugs, therapies, and solutions in the field of medical research. The company was originally founded in 2000 and is headquartered in Burlingame, California. One major focus of Humanigen Inc is the treatment of severe and life-threatening diseases such as cancer or HIV/AIDS that have not been sufficiently addressed by other medications. The company has developed a range of special technologies that enable it to develop innovative and effective therapies and drugs. An important aspect of Humanigen Inc's business model is collaboration with other companies, institutions, and research facilities worldwide. Through partnerships and cooperation, the company is able to cover the entire spectrum of research and development, allowing it to develop treatment options even faster and more effectively. Humanigen Inc has several different divisions and products designed for various applications. An important subsidiary of the company is the Humanigen Center for HIV Cure Research, which specifically focuses on combating HIV. There, the company works closely with scientists, researchers, and partners to develop new and innovative treatment options. Another important product of Humanigen Inc is the drug Lenzilumab. Lenzilumab is an antibody used to treat severe and life-threatening diseases such as cancer and COVID-19. Lenzilumab has shown great promise in clinical trials and could be the key to developing new and effective treatment options. In addition, Humanigen Inc has filed a variety of patents that enable it to develop new and innovative technologies in medical research. Many of these technologies are also licensed by other companies and research institutions, promoting the growth and expansion of Humanigen Inc. In recent years, the company has also placed a major focus on the field of digital technology. By utilizing big data, artificial intelligence, and other digital technologies, Humanigen Inc is able to develop new therapy options even faster and more effectively, catering specifically to the needs of patients and doctors. Overall, Humanigen Inc is an innovative and rapidly growing company focused on the development of new and effective treatment options for serious diseases. Through collaboration with other companies and institutions, the development of new technologies, and a targeted focus on the needs of patients and doctors, the company is able to respond even faster and more effectively to challenges in the field of medical research. Humanigen ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Humanigen's Return on Capital Employed (ROCE)
Humanigen's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Humanigen's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Humanigen's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Humanigen’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Humanigen stock
How has the ROCE (Return on Capital Employed) of Humanigen developed compared to the previous year?
The ROCE of Humanigen has increased by 0% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Humanigen?
A high Return on Capital Employed (ROCE) indicates that Humanigen has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Humanigen?
A low ROCE (Return on Capital Employed) can indicate that Humanigen has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Humanigen impact the company?
An increase in the ROCE of Humanigen can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Humanigen affect the company?
A decrease in ROCE of Humanigen can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Humanigen?
Some factors that can affect Humanigen's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Humanigen so important for investors?
The ROCE of Humanigen is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Humanigen take to improve the ROCE?
To improve the ROCE, Humanigen can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Humanigen pay?
Over the past 12 months, Humanigen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Humanigen is expected to pay a dividend of 0 USD.
What is the dividend yield of Humanigen?
The current dividend yield of Humanigen is .
When does Humanigen pay dividends?
Humanigen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Humanigen?
Humanigen paid dividends every year for the past 0 years.
What is the dividend of Humanigen?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Humanigen located?
Humanigen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Humanigen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Humanigen from 3/13/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/13/2025.
When did Humanigen pay the last dividend?
The last dividend was paid out on 3/13/2025.
What was the dividend of Humanigen in the year 2024?
In the year 2024, Humanigen distributed 0 USD as dividends.
In which currency does Humanigen pay out the dividend?
The dividends of Humanigen are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Humanigen
Our stock analysis for Humanigen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humanigen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.